PERSONAL DATA Name: David L. McCann, M.D., D.L.F.A.P.A. 4190 Highland Drive, Suite 102 Salt Lake City, UT 84124 Phone (801) 272-9205 Fax (801) 272-9208 Medical Specialty: Psychiatry. General Adult Psychiatry. Organizational and Occupational Psychiatry. Independent Medical Evaluations. EDUCATION Bachelor of Science in Molecular and Genetic Biology 1962-1967 University of Utah Salt Lake City, Utah 84112 Doctor of Medicine Degree 1967-1971 University of Maryland School of Medicine Lombard and Green Street, Baltimore, Maryland 21218 Residency in Psychiatry 1971-1972 Duke University Durham, North Carolina 72204 Residency in Psychiatry 1972-1974 University of Utah College of Medicine 50 North Medical Drive Salt Lake City, Utah 84113 BOARD CERTIFICATION Diplomate, American Board of Psychiatry and Neurology, Inc. - Psychiatry 1977 PROFESSIONAL EXPERIENCE 1974-1977 Staff Psychiatrist - V.A. Hospital, Salt Lake City, Utah 1976-Present Private Practice - Salt Lake City, Utah 1986 Adult Services Director - CPC-Olympus View Hospital, Salt Lake City, Utah 1986-1989 Medical Director, Alcohol and Chemical Dependency Treatment - CPC-Olympus View Hospital, Salt Lake City, Utah 1987-1989 Medical Director - CPC-Olympus View Hospital, Salt Lake City, Utah 1988-1996 Appointed Member, Utah Physician’s Licensing Board 1995 Editorial Consultant - Journal of Behavior Therapy and Experimental Psychiatry
2004-2005 Re-appointed to Utah Physician Licensing Board 2006-2012 Governing Board, Academy of Organizational and Occupational Psychiatry 30+ years of complex Independent Medical Evaluations have been provided for a wide variety of clients over the past 30 years or more. PROFESSIONAL AND COMMUNITY ACTIVITIES 1980 Course Moderator, “Common Psychiatric Problems” - Annual Scientific Meeting of the Utah State Medical Association 1980-1981 President, Utah Psychiatric Association 1982-1986 Elected Member and Chairman - Credentials Committee, St. Mark's Hospital 1986 Executive Committee - CPC-Olympus View Hospital 1993 Site Investigator: "The Multicenter Trial for Efficacy and Safety of Sertraline in the Treatment of Major Depression", Protocol #R-010908. Quintiles Pacific, Inc. for Rorig Division Pharmaceuticals Group, Pfizer, Inc. 1999 David L. McCann - “Posttraumatic Stress Disorder in the Workplace,” Intracorp, (audience of disability, rehabilitation managers and evaluators) 2000 David L. McCann - Psychiatric Issues in the Workplace, Salt Lake City Corporation (presented to a multi-disciplinary group of personnel managers) MEMBERSHIP IN PROFESSIONAL SOCIETIES Utah Medical Association American Medical Association Utah Psychiatric Association American Psychiatric Association Academy of Organizational and Occupational Psychiatry Fellow - American Psychiatric Association, 1987 Distinguished Fellow, American Psychiatric Association, 2003 Distinguished Life Fellow, American Psychiatric Association, 2006 TEACHING RESPONSIBILITIES/ASSIGNMENTS 1974-2000 Clinical Instructor of Psychiatry - University of Utah School of Medicine 2000 Clinical Assistant Professor of Psychiatry - University of Utah School of Medicine BIBLIOGRAPHY Publications: McCann, David L., 1992: "Posttraumatic Stress Disorder Due to Devastating Burns Overcome by Single Session of Eye Movement Desensitization," Journal of Behavior Therapy and Experimental Psychiatry, Volume 23, #4. McCann, David L., 1997: “EMDR” (1992 article published as a chapter of a book in German. McCann, David L., 2005: “Arbitration: Make It Work for You!”, Utah Psychiatric
Association News, Spring 2005 Issue/February. McCann, David L., 2010: “Utah Courts Have Determined That Independent Medical Examiners Cannot Be Sued for Malpractice” PRESENTATIONS David L. McCann, M.D., 1990: "Psychiatric Impairment and Chronic Soft Tissue Pain", Rocky Mountain Center for Occupational and Environmental Health, Conference on Managing Compensable Disability. David L. McCann, M.D., 1992: "Antidepressants", St. Mark's Hospital Division of Family Practitioners David L. McCann, M.D., 1999: “EMDR, Basic Methods,” University of Utah Neuropsychiatric Institute - presentation to medical staff David L. McCann, M.D., 2000: “Emotional Effects of Malpractice Litigation,” Utah Medical Insurance Association (presented to UMIA insured physicians) David L. McCann, M.D., February 2, 2002: “PTSD With EMDR Therapy”, University of Utah Neuropsychiatric Institute, Psychiatric Noon Conference. David L. McCann, M.D., August 20, 2002: “Tracking Medication to Augment Treatment”, University of Utah Neuropsychiatric Institute, Psychiatric Noon Conference. David L. McCann, April 9, 2003: “Practical Aspects of Living With Someone Who Has Mental Illness, and Support for Family Members Who Have Anxiety and Depression”, NAMI-Utah-Salt Lake City. David L. McCann, November 2, 2004: “Trauma, PTSD, and Conversion Disorder, Cause and Effect”, University of Utah Neuropsychiatric Institute, Psychiatric Noon Conference. David L. McCann, January 17, 2007: “Psychiatric Consequences of Injury – Determination of Cause”, Workers Compensation Fund of Utah. David L. McCann, April 15, 2007: “Posttraumatic Stress Disorder and Conversion Disorder – Determination of Cause in the Context of Injury Claims”, AOOP 18th Annual Meeting, Chicago, Illinois David L. McCann, March 16, 2008: “Treating Occupational PTSD to Resolution. Building a Traumatic Incident Intervention Program with Industry”, AOOP 19th Annual Meeting, Chicago, Illinois David L. McCann, November, 2011: “Postal Service Criteria for Assessing Risk for Violence”, AOOP, 22nd Annual Meeting, Chicago, Illinois
Web of Science: Citation Indexing for Journals in All Disciplines Connect to Web of Science from the Merrill-Cazier Library website , http://library.usu.edu/. Use the “Find a Database” feature on the homepage. Or click Find Resources, then Electronic Resources & Databases , then click “W” in the alphabetical list. Combines access to Science Citation Inde
MATERIAL SAFETY DATA SHEET Personal Protective Equipment See Section 8. 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Product code: Product Name: Chemical Name: 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, monohydrochloride hydrate Synonyms: 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(